Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02266576 · ClinicalTrials.gov registry record · NA

A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American Indians

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
207
Enrollment target

NCT02266576: Completed NA study, sponsored by Stanford University.

NCT02266576 is a NA study that has completed, run by Stanford University. The registered enrollment target is 207 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02266576, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
207 participants
Enrollment target

Study Summary

The goal of the proposed research is to identify effective patient-centered strategies to prevent diabetes in high-risk populations in real world settings. The investigators will accomplish this by conducting a randomized controlled trial comparing an enhanced Diabetes Prevention Program addressing psychosocial stressors to a standard version in a high-risk population of urban American Indian and Alaska Native people within a primary care setting.

Interventions

  • BEHAVIORAL Standard DPP
  • BEHAVIORAL Enhanced DPP

Trial Details

FieldValue
Enrollment Target 207 participants
Start Date 2015-06
Est. Completion 2017-08-30
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT02266576

The ClinicalTrials.gov registry entry for NCT02266576 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 207 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Standard DPP is the first listed.

NCT02266576 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02266576 about?

NCT02266576 is a clinical study titled "A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American Indians". The goal of the proposed research is to identify effective patient-centered strategies to prevent diabetes in high-risk populations in real world settings. The investigators will accomplish this by conducting a randomized controlled trial comparing an enhanced Diabetes Prevention Program addressing ...

What is the current status of trial NCT02266576?

This trial is currently completed. It is a NA study. The enrollment target is 207 participants. The study started on 2015-06. Estimated completion is 2017-08-30.

What interventions are being tested in trial NCT02266576?

The interventions under investigation include: Standard DPP (BEHAVIORAL), Enhanced DPP (BEHAVIORAL).

Who is sponsoring clinical trial NCT02266576?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.